Professor Colin Dayan



Projects as PI
Go to first page Go to previous page 1 of 7 Go to next page Go to last page

Albiglutide versus placebo in insulin-treated subjects with new-onset Type 1 Diabetes mellitus - Funder:Cardiff & Vale University Health Board (22/01/2015 - 31/03/2020)
Clinical Trial - Funder:Cardiff & Vale University Health Board (01/12/2015 - 31/03/2020)
Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger smarter faster - Funder:Juvenile Diabetic Research Foundation, - Funder:Diabetes UK (01/05/2019 - 30/04/2022)


Projects as Co-Investigator
Go to first page Go to previous page 1 of 3 Go to next page Go to last page

A new window into the immune response funding during Type 1 Diabetes - Funder:Wellcome Trust (01/11/2017 - 31/05/2019)
B cells in newly diagnosed type 1 diabetes - Funder:Diabetes UK (01/03/2012 - 31/07/2016)
Bringing immunotherapy for type 1 diabetes into the clinic: New windows into the immune response - Funder:Diabetes Research & Wellness Foundation (01/05/2018 - 30/04/2019)
Cardiovascular disease research - Funder:Cardiac Research & Development Fund (01/11/2013 - 31/10/2016)
Development of urinary microRNAs as biomarkers for diabetic kidney disease - Funder:National Institute for Health Research (01/04/2013 - 31/07/2018)

Last updated on 2020-05-07 at 04:06